Carina Elsner

Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease

Lukas van de Sand, Maren Bormann, Mira Alt et al. · Viruses · 2021 · 188 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19

Birte Möhlendick, Kristina Schönfelder, Katharina Breuckmann et al. · Pharmacogenetics and Genomics · 2021 · 136 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +11

GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine

Ieva Čiučiulkaitė, Birte Möhlendick, Laura Thümmler et al. · Frontiers in Genetics · 2022 · 132 citations · Full text

Life Sciences, Genetics, Immunology +17

Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection

Michel Bazinet, Victor Pântea, Valentin Cebotarescu et al. · Hepatology Communications · 2020 · 84 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study

Kristina Schönfelder, Katharina Breuckmann, Carina Elsner et al. · Frontiers in Genetics · 2021 · 77 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16